Table 3 Univariate and multivariate analysis of factors associated with BRFS
From: Neutrophil count is associated with survival in localized prostate cancer
| Â | Univariate | Multivariate | ||
|---|---|---|---|---|
| Â | HR (95Â % CI) | p-value | HR (95Â % CI) | p-value |
Age (n = 1041) | 0.98 (0.94–1.01) | 0.2 | 0.94 (0.91–0.98) | 0.009 |
CAPRA (n = 1041) | 1.23 (1.11–1.37) | 0.0001 | 1.26 (1.12–1.43) | 0.0002 |
BMI (n = 372) | 1.02 (0.97–1.08) | 0.5 |  |  |
CVD (n = 1044) | 0.73 (0.46–1.16) | 0.2 |  |  |
Diabetes (n = 1044) | 0.86 (0.44–1.67) | 0.7 |  |  |
Statin use (n = 1044) | 0.79 (0.50–1.24) | 0.3 | 0.67 (0.39–1.17) | 0.2 |
Neutrophils (n = 608) | 1.04 (0.87–1.23) | 0.7 |  |  |
Lymphocytes (n = 609) | 0.98 (0.64–1.48) | 0.9 |  |  |
NLR (n = 608) | 1.02 (0.85-1.22) | 0.9 |  |  |